Benjamin R. Yerxa
- Physiology top 0.5%
- Public Health, Environmental and Occupational Health top 5%
- Molecular Biology
- Ophthalmology top 2%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Ward PetersonJames G. DouglassMatthew S. CowlenSammy R. ShaverR. W. DoughertyKunyan KuangJorge FischbargJosé L. Boyer
- Topics
- Adenosine and Purinergic Signaling (16 papers)Glaucoma and retinal disorders (9 papers)Ocular Surface and Contact Lens (8 papers)
- Journals
- SHILAP Revista de lepidopterologíaJournal of Medicinal ChemistryJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Benjamin R. Yerxa
49 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 90
- Physiology 463
- Public Health, Environmental and Occupational Health 443
- Molecular Biology 398
- Ophthalmology 313
- Radiology, Nuclear Medicine and Imaging 210
Countries citing papers authored by Benjamin R. Yerxa
This map shows the geographic impact of Benjamin R. Yerxa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin R. Yerxa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin R. Yerxa more than expected).
Fields of papers citing papers by Benjamin R. Yerxa
This network shows the impact of papers produced by Benjamin R. Yerxa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin R. Yerxa. The network helps show where Benjamin R. Yerxa may publish in the future.
Co-authorship network of co-authors of Benjamin R. Yerxa
This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin R. Yerxa. A scholar is included among the top collaborators of Benjamin R. Yerxa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin R. Yerxa. Benjamin R. Yerxa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | A 12-Month Study of the ENV515 (Travoprost) Intracameral Implant on Intraocular Pressure in Beagle Dogs | 1 |
| 2 | Extended PGA Delivery Results in Significant Drug Sparing Compared to Topical PGAs and Achieves Sustained IOP Lowering for 11 Months without Any Loss of Efficacy | 2 |
| 3 | 8 | |
| 4 | Extended release aflibercept with sustained vitreous concentration in non-human primates from biodegradable hydrogel implants | 1 |
| 5 | In-Vitro Release of Bevacizumab from Hydrogel-based Drug Delivery Systems | 2 |
| 6 | Precisely Engineered Biodegradable Drug Delivery Systems for the Extended Release of Prostaglandin Analogues in the Anterior Chamber | 1 |
| 7 | Photocurable Hydrogel Implants for the Extended Release of Bevacizumab for the Treatment of Age Related Macular Degeneration | 2 |
| 8 | Intracameral Conversion of Travoprost to Travoprost Acid in the Normotensive Beagle Dog Model | 2 |
| 9 | Controlled and Extended Release of Difluprednate from Biodegradable Intraocular Implants Engineered using PRINT® Technology | 1 |
| 10 | 12 | |
| 11 | Extended Release of Microfabricated Protein Particles from Biodegradable Hydrogel Implants for the Treatment of Age Related Macular Degeneration | 3 |
| 12 | Precisely Engineered Biodegradable Intraocular Implants for the Sustained Release of Dexamethasone | 1 |
| 13 | Suprachoroidal Microinjection of Bevacizumab is Well Tolerated in Human Patients | 6 |
| 14 | Topical application of nucleotides increase lysozyme levels in tears | 1 |
| 15 | In vitro Analysis of the Antagonism of the Histamine H1 Receptor by Epinastine: A Kinetic Comparison With Other Marketed Compounds | 3 |
| 16 | 29 | |
| 17 | 6 | |
| 18 | 17 | |
| 19 | 131 | |
| 20 | 25 |
About Benjamin R. Yerxa
Benjamin R. Yerxa is a scholar working on Physiology, Ophthalmology and Endocrine and Autonomic Systems, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (16 papers), Glaucoma and retinal disorders (9 papers) and Ocular Surface and Contact Lens (8 papers). The work is most often cited by research in Physiology (463 citations), Ophthalmology (313 citations) and Endocrine and Autonomic Systems (181 citations). Benjamin R. Yerxa has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Ward Peterson, James G. Douglass, Matthew S. Cowlen, Sammy R. Shaver, R. W. Dougherty, Kunyan Kuang, Jorge Fischbarg, José L. Boyer, William Pendergast and Quan Wen. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.